May 30 (Reuters) - CSL Ltd (CSL) :
- CSL: SELECTED BY BARDA TO COMPLETE FILL AND FINISH PROCESS OF PRE-PANDEMIC VACCINE FOR U.S. GOVERNMENT AS PART OF NPIVS PROGRAM
- CSL: CSL SEQIRUS WILL DELIVER ABOUT 4.8 MILLION DOSES OF PRE-PANDEMIC VACCINE THAT IS WELL-MATCHED TO H5 OF CURRENTLY CIRCULATING H5N1 STRAIN
- CSL: FACILITY IN HOLLY SPRINGS CAN DELIVER UP TO 150 MILLION INFLUENZA VACCINE DOSES TO SUPPORT PANDEMIC RESPONSE WITHIN 6 MONTHS OF PANDEMIC DECLARATION
News: CSL CSL Selected By Barda To Complete Fill And Finish Process Of Pre-Pandemic Vaccine For...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$248.07 |
Change
0.615(0.25%) |
Mkt cap ! $120.0B | |||
| Open | High | Low | Value | Volume |
| $247.65 | $249.87 | $245.75 | $131.6M | 529.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 55 | $248.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $248.07 | 46 | 5 |
View Market Depth
| Last trade - 15.58pm 17/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |